<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03496610</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00087144</org_study_id>
    <nct_id>NCT03496610</nct_id>
  </id_info>
  <brief_title>Surgeon Infiltration QL Block Comparison</brief_title>
  <official_title>Intraoperative Surgical Wound Infiltration vs Quadratus Lumborum (QL) Block for Post-operative Pain Control After Nephrectomy in Living Donor Kidney Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn if using a Quadratus Lumborum (QL) plane injection&#xD;
      technique (also called a &quot;nerve block&quot;) that numbs the nerves going to the abdominal area&#xD;
      improve pain control after surgery compared to administration of local anesthetic directly to&#xD;
      the surgical incision. The QL block technique uses a numbing solution (local anesthetics)&#xD;
      that is injected next to nerves located along muscles in the back to reduce pain. This block&#xD;
      will not affect movement in the leg and/or make the legs weak. Some institutions, including&#xD;
      Duke, use the QL block for patients having various abdominal surgeries, with the hope of&#xD;
      providing good pain relief combined with improved mobility after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>Up to 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric pain scores as measured by the NRS 11</measure>
    <time_frame>Up to 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of GI Complications</measure>
    <time_frame>Up to 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity after surgery as measured by walking test</measure>
    <time_frame>Up to 7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Quadratus Lumborum Block</condition>
  <condition>Surgical Wound Infiltration</condition>
  <arm_group>
    <arm_group_label>Quadratus Lumborum (QL) Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a bilateral ultrasound guided QL block by the anesthesia team.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical wound infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 166 mg of liposomal bupivacaine mixed with 50 mg non-liposomal bupivacaine infiltrated into the wound by the surgeon.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal Bupivicaine</intervention_name>
    <description>Patient will receive liposomal bupivicaine mixed with non-liposomal bupivicaine directly to wound</description>
    <arm_group_label>Surgical wound infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>QL Block</intervention_name>
    <description>Patient will receive ultrasound guided QL Block</description>
    <arm_group_label>Quadratus Lumborum (QL) Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  ASA 1-2 patients undergoing living donor nephrectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA 3 or 5&#xD;
&#xD;
          -  Diagnosis of chronic pain&#xD;
&#xD;
          -  Daily chronic opioid use (over 3 months of continuous opioid use)&#xD;
&#xD;
          -  Inability to communicate pain scores or need for analgesia&#xD;
&#xD;
          -  Infection at the site of block placement&#xD;
&#xD;
          -  Pregnant women (as determined by standard of care day-of surgery urine bHCG)&#xD;
&#xD;
          -  Intolerance/allergy to local anesthetics&#xD;
&#xD;
          -  Weight &lt;50 kg&#xD;
&#xD;
          -  Suspected or known addiction to or abuse of illicit drug(s), prescription medicine(s),&#xD;
             or alcohol within the past 2 years&#xD;
&#xD;
          -  Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the&#xD;
             opinion of the investigator, may interfere with study assessments or compliance&#xD;
&#xD;
          -  Current or historical evidence of any clinically significant disease or condition&#xD;
             that, in the opinion of the investigator, may increase the risk of surgery or&#xD;
             complicate the subject's postoperative course&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hector Martinez-Wilson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hector Martinez-Wilson, MD</last_name>
    <phone>617-513-3224</phone>
    <email>hector.martinez-wilson@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hector Martinez-Wilson</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 5, 2018</study_first_submitted>
  <study_first_submitted_qc>April 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bupivacaine</keyword>
  <keyword>Living donor nephrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

